chlorzoxazone has been researched along with Central Nervous System Disease in 1 studies
Chlorzoxazone: A centrally acting central muscle relaxant with sedative properties. It is claimed to inhibit muscle spasm by exerting an effect primarily at the level of the spinal cord and subcortical areas of the brain. (From Martindale, The Extra Pharmacopoea, 30th ed, p1202)
chlorzoxazone : A member of the class of 1,3-benzoxazoles that is 1,3-benzoxazol-2-ol in which the hydrogen atom at position 5 is substituted by chlorine. A centrally acting muscle relaxant with sedative properties, it is used for the symptomatic treatment of painful muscle spasm.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Their anti-HPNS properties, like those previously established for the mephenesin group of centrally acting muscle relaxants, seem to be related to their ability to antagonize the convulsive action of strychnine." | 1.27 | Effect of benzazole-related centrally acting muscle relaxants on HPNS. ( Bowser-Riley, F; Daniels, S; Smith, EB, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bowser-Riley, F | 1 |
| Daniels, S | 1 |
| Smith, EB | 1 |
1 other study available for chlorzoxazone and Central Nervous System Disease
| Article | Year |
|---|---|
Effect of benzazole-related centrally acting muscle relaxants on HPNS.
Topics: Animals; Benzimidazoles; Central Nervous System Diseases; Chlorzoxazone; High Pressure Neurological | 1988 |